another platinum digit here

Chief Scientific Officer : Dr. Krishna Menon: Nearly 30 highly-relevant years in the drug development industry including being a recipient of the President’s Award during his time as a Research Associate at Eli Lilly for his instrumental role in choosing Alimta and Gemzar for development as cancer therapies. These blockbuster chemotherapies are still two of the most widely used drugs today and generated more than $3.3 billion in sales last year alone.